XML 97 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Oct. 13, 2023
Mar. 01, 2023
Jan. 19, 2023
Aug. 08, 2022
Jul. 27, 2022
Jun. 30, 2020
Dec. 24, 2019
Dec. 31, 2023
Dec. 31, 2022
Apr. 27, 2023
Jan. 18, 2023
Dec. 06, 2022
Jul. 26, 2022
Subsidiary, Sale of Stock [Line Items]                          
Gross proceeds from the sale of stock               $ 104,686 $ 100,000        
Offering costs               $ 619 $ 111        
Increase in common stock, shares authorized (in shares)     650,000,000   100,000,000                
Common stock, shares authorized (in shares)     1,000,000,000   350,000,000     1,000,000,000 1,000,000,000   350,000,000   250,000,000
Common stock par value (in dollars per share)               $ 0.01 $ 0.01 $ 0.01   $ 0.01  
Proceeds from the issuance of common stock via private placement               $ 5,000 $ 0        
Number of common stock shares into which each warrant converts (in shares)               1          
Warrants outstanding (in shares)               5,015,642 5,821,137        
Chief Operations Officer                          
Subsidiary, Sale of Stock [Line Items]                          
Proceeds from the issuance of common stock via private placement $ 5,000                        
Duggan February Note | Chief Executive Officer                          
Subsidiary, Sale of Stock [Line Items]                          
Promissory note                       $ 400,000  
Consulting Agreement | Affiliated entity                          
Subsidiary, Sale of Stock [Line Items]                          
Number of common stock shares into which warrants may be converted (in shares)             3,358,732            
Exercise price of warrants (in dollars per share)             $ 1.44            
Warrants quarterly vesting period             3 years            
Consulting Agreement | Affiliated entity | Warrants                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants cancelled (in shares)           2,798,945              
Warrants outstanding (in shares)               559,787          
Rights Offering                          
Subsidiary, Sale of Stock [Line Items]                          
Gross proceeds from the sale of stock   $ 500,000   $ 100,000                  
Shares issued (in shares)   476,190,471   103,092,783                  
Sale of stock price (in dollars per share)   $ 1.05   $ 0.97                  
Offering costs   $ 619   $ 111                  
Issuance of common stock               $ 395,314 $ 0        
Rights Offering | Chief Executive Officer                          
Subsidiary, Sale of Stock [Line Items]                          
Issuance of common stock   $ 395,314                      
Private placement                          
Subsidiary, Sale of Stock [Line Items]                          
Number of common stock shares into which warrants may be converted (in shares)             5,261,350            
Exercise price of warrants (in dollars per share)             $ 1.58            
Number of common stock shares into which each warrant converts (in shares)             1            
Minimum volume weighted average common stock price to warrant exercise price, premium, percentage             50.00%            
Private placement | Chief Operations Officer                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued (in shares) 2,976,190                        
Sale of stock price (in dollars per share) $ 1.68                        
S-3 Registration Statement | Chief Executive Officer                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares registered for resale (in shares)                   9,346,434      
S-3 Registration Statement | Related party                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares registered for resale (in shares)                   10,000,000      
S-3 Registration Statement | Chief Executive Officer and President                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares registered for resale (in shares)                   373,857